Publicacións (19) Publicacións de Estela Fernández Salgado

2023

  1. Benefits of Paediatric to Adult Transition Programme in Inflammatory Bowel Disease: The BUTTERFLY Study of GETECCU and SEGHNP

    Journal of Clinical Medicine, Vol. 12, Núm. 14

2022

  1. Correction: Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study (J. Clin. Med., (2021), 10, (2885), 10.3390/jcm10132885)

    Journal of Clinical Medicine

  2. Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study

    Inflammatory bowel diseases, Vol. 28, Núm. 11, pp. 1725-1736

  3. Management and Long-term Outcomes of Crohn's Disease Complicated with Enterocutaneous Fistula: ECUFIT Study from GETECCU

    Journal of Crohn's & colitis, Vol. 16, Núm. 7, pp. 1049-1058

  4. Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn’s Disease Patients on Ustekinumab

    Journal of Clinical Medicine, Vol. 11, Núm. 15

2021

  1. Effectiveness of ustekinumab in fistulising perianal Crohn′s disease refractory or intolerant to anti-TNF

    Journal of Crohn's and Colitis, Vol. 15, Núm. Supplement_1, pp. S419-S420

  2. Incidence, clinical characteristics and management of inflammatory bowel disease in spain: Large-scale epidemiological study

    Journal of Clinical Medicine, Vol. 10, Núm. 13

  3. Risk and predictors of surgery in a newly diagnosed cohort of IBD patients in the biologic era: Results from the EpidemIBD study

    Journal of Crohn's and Colitis, Vol. 15, Núm. Supplement_1, pp. S018-S020

2020

  1. Efectividad del plan de contingencia de la Unidad de Enfermedad Inflamatoria Intestinal ante la infección de Covid-19

    Revista espanola de salud publica, Vol. 94

2016

  1. Effectiveness of anti-TNFα drugs in patients with Crohn's disease who do not achieve remission with their first anti-TNFα agent

    Digestive and Liver Disease, Vol. 48, Núm. 6, pp. 613-619

  2. Ocular Toxoplasmosis Reactivation in a Patient with Inflammatory Bowel Disease under Treatment with Azathioprine

    Journal of Clinical Gastroenterology

  3. Tuberculosis in anti-tumour necrosis factortreated inflammatory bowel disease patients after the implementation of preventive measures: Compliance with recommendations and safety of retreatment

    Journal of Crohn's and Colitis, Vol. 10, Núm. 10

2014

  1. Biosimilares : ¿qué son?, ¿para qué sirven?

    Inflamatoria: Revista oficial del grupo EIGA, Núm. 8, pp. 2-5

2011

  1. Tiopurinas y riesgo de linfoma en enfermedad inflamatoria intestinal

    Inflamatoria: Revista oficial del grupo EIGA, Núm. 6, pp. 16-20

2010

  1. Pólipo rectal como forma de presentación de colitis quística profunda

    Revista Espanola de Enfermedades Digestivas, Vol. 102, Núm. 1, pp. 53-54

2009

  1. Gastric xanthoma on a hyperplastic polyp

    Gastroenterologia y Hepatologia

2008

  1. Pseudoachalasia of the cardia secondary to nongastrointestinal neoplasia

    Dysphagia, Vol. 23, Núm. 2, pp. 122-126

2007

  1. Evaluation of the bilio-pancreatic region using endoscopic ultrasonography in patients referred with and without abdominal pain and CA 19-9 serum level elevation

    Journal of the Pancreas, Vol. 8, Núm. 2, pp. 191-197

  2. Radial endoscopic ultrasonography and buried bumper endoscopic solution

    Surgical Laparoscopy, Endoscopy and Percutaneous Techniques, Vol. 17, Núm. 3, pp. 201-202